Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoprecipitate for prevention of traumatic brain contusion expansion
IRCT20190729044375N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Feb 2021
- Modality
- Tissue Cells → Other Cell Types → Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of cryoprecipitate in traumatic intracerebral hemorrhage and cerebral contusion (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Intraparenchymal hematoma size of brain tissue. Started Feb 2021; status: completed.
02
Drugs
cryoprecipitate
03
Conditions
traumatic intracerebral hemorrhagecerebral contusion
Beyond the preview
Go deeper on IRCT20190729044375N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190729044375N1.